Pure Global

N-terminal pro B-type Natriuretic Peptide - India CDSCO Medical Device Registration

N-terminal pro B-type Natriuretic Peptide is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000117_7b046d58feb7e705010aa3674cbb510a_f8aac05f4b4406fb5e9a41eff5bdf5d8. This device is marketed under the brand name eCLIA. The license holder is Q-Line Biotech Private Limited (Formerly Known As POCT SERVICES PRIVATE LIMITED), and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
N-terminal pro B-type Natriuretic Peptide
UID: IMP/IVD/2022/000117_7b046d58feb7e705010aa3674cbb510a_f8aac05f4b4406fb5e9a41eff5bdf5d8

Brand Name

eCLIA

Device Class

Class C

Approving Authority

CDSCO

Product Information

Immunoassay for the in vitro quantitative determination of N-terminal pro B-type natriuretic peptide in human plasma

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing